key: cord-0771614-1ajwst5s
authors: Timbrook, Tristan; Maxam, Meshell; Bosso, John
title: Antibiotic Discontinuation Rates Associated with Positive Respiratory Viral Panel and Low Procalcitonin Results in Proven or Suspected Respiratory Infections
date: 2015-09-05
journal: Infect Dis Ther
DOI: 10.1007/s40121-015-0087-5
sha: 4230f45cdf439e789aa57cbb1a080823c74d7e8a
doc_id: 771614
cord_uid: 1ajwst5s

INTRODUCTION: The differentiation of viral from bacterial pneumonia is important in determining whether antibiotics are appropriate for treatment of these infections. Advances in diagnostic technologies such as respiratory panels (RP) utilizing polymerase chain reactions to detect viruses and determination of procalcitonin (PCT) concentrations may aid in this differentiation. However, some studies have shown limited impact for this purpose and thus continuation of antibiotics despite results suggesting viral infection. Our objective was to characterize clinician-prescribing behavior at our institution once RP and/or PCT results were known and suggestive of a viral respiratory infection. METHODS: This retrospective analysis was based upon records of hospitalized patients in whom proven or possible respiratory infections as indicated by RP testing, respiratory bacterial culture or International Statistical Classification of Diseases and Related Health Problems 9th revision codes for acute infectious respiratory illness was documented. Patients evaluated were required to have a RP or PCT within the first 72 h of presentation. Drug orders were evaluated for discontinuation of antibiotic therapy within 48 h of a procalcitonin of <0.25 μg/mL, a positive viral RP result, or both. RESULTS: Of 4869 patients with PCT and/or RP results, 2031 were included. PCT and RP testing were obtained in 503 and 1823 patients, respectively, with 295 patients having both. Results of these tests suggested 789 patients were potential candidates for antibiotic avoidance. These included 219 with a PCT <0.25 μg/mL, 601 with a positive viral RP result, and 31 with both. Antibiotics were administered to 307 patients (39%) within the first 72 h. In these, antibiotics were discontinued within 48 h of laboratory results availability. CONCLUSION: These results suggest that positive viral RP and low PCT results are infrequently associated with discontinuation of antibiotic therapy in proven or possible respiratory infections at our institution. Direct interventions with clinicians are likely needed to correct this behavior and decrease unnecessary antibiotic use. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s40121-015-0087-5) contains supplementary material, which is available to authorized users.

Results: Of 4869 patients with PCT and/or RP results, 2031 were included. PCT and RP testing were obtained in 503 and 1823 patients, respectively, with 295 patients having both.

Results of these tests suggested 789 patients were potential candidates for antibiotic avoidance. These included 219 with a INTRODUCTION Pneumonia remains among the top 10 most common causes of mortality for all age groups in the United States and the most common infectious cause of mortality [1] . In the United States in 2013, pneumonia was responsible for 1.1 million hospital admissions and 53,282 deaths [2] . Pneumonia is commonly caused by viral or bacterial pathogens with the former being responsible for 29-39% of cases [3, 4] . Clinical signs and symptoms associated with the two etiologies are often indistinguishable [5] . Despite the advances in and clinical application of such diagnostic technologies, it has been reported that many patients nonetheless continue to receive antibiotic therapy without regard to positive viral PCR and/or low PCT results [14] [15] [16] . It was our objective to determine the frequency of changes in empiric antibiotic therapy for known or proven cases of pneumonia once results of respiratory panels (RP) and/or PCT testing were known to the clinician and thus determine the need for an active stewardship intervention at our own institution.

This retrospective, single-center study was Additionally, patients with COPD, chronic bronchitis, or emphysema were excluded as a lack of utility of PCT in distinguishing viral from bacterial respiratory illness in COPD has been described [17] . Basic study/design flow is illustrated in Fig. 1 .

Procalcitonin concentrations were determined with the VIDAS BRAHMS PCT automated test (bioMérieux, Marcy, France). PCT has a reported sensitivity of 88% and specificity of 81% in distinguishing a bacterial infection from other inflammatory processes [18] . Routine laboratory reporting denotes values of. 25 

Of 4869 individual patient records with PCT and/or RP results, 2031 met inclusion for the study (Fig. 1) lg/mL, a positive PCR, or both ( Table 2 ). The median duration of antibiotics was 3 days for all [19] . In the outpatient setting including the emergency department, the majority of antibiotic prescribing has been for patients presenting with respiratory conditions [20] .

Many such infections are of viral origin including nearly 30% of pneumonias [3, 4] . In turn, much antibiotic prescribing for respiratory infections in outpatients is unwarranted [21, 22] . Unnecessary antibiotic use in the hospitalized patients with apparent respiratory tract infections also occurs [23] . This overuse can be explained to a large extent by the inherent difficulty in clinically differentiating bacterial from viral infection. At the same time, it appears that the treatment of respiratory tract infections represents a major area of opportunity for more judicious and limited use of antibiotics. The utilization of rapid diagnostic tests may help with this differential.

The use of PCT and RP alone, or in combination, has been successfully and safely used to guide diagnosis and therapy [13, [24] [25] [26] [27] .

A number of studies have shown PCT to be an effective test to utilize in altering antibiotic prescribing patterns without adversely affecting patient outcomes [13, 24, 25] . In these studies, empiric antibiotics therapy was strongly IQR interquartile range, PCT procalcitonin, RP respiratory panel in antibiotic duration when that information was made available to the primary care provider [26] . Patients in whom the positive viral RP was disclosed to the primary care provider (n = 11) had a median duration of antibiotics of 7 days as opposed to 12 days (P = 0.05) in patients with proven bacterial infection (n = 28).

Furthermore, when a positive viral PCR was not disclosed (n = 19), the median duration of antibiotics was 12 days-similar to the bacterial infection group. These findings of decreased antibiotic exposure based on viral PCR were also reported by Oosterheert and colleagues [27] . In their study, positive PR results led to a discontinuation of antibiotics in 11% of patients.

One potential challenge of the reliance on these rapid tests to rule out bacterial infection is co-infection with viral and bacterial pathogens, which has been reported in 14 [32, 33] .

We studied clinician-prescribing behavior at our institution once RP and/or PCT laboratory results were available to the prescribing physician and were suggestive of a pure viral respiratory infection. We observed antibiotic discontinuation rates of only 17-20% in patients with positive viral RP results or PCT.25 lg/mL. In patients with both test results available (n = 31), and highly suggestive of a pure viral infection, antibiotic discontinuation rates were even lower (10%).

One possible explanation for the low rates of antibiotic discontinuation could relate to the relatively low prescribing of antibiotics (38.9%) to patients with proven or suspected respiratory infections which had either a low PCT, a positive viral RP result, or both. We believe the relatively low incidence of prescribing in this context suggests many prescribers avoided antibiotic therapy based on other clinical factors suggesting a non-bacterial illness causing respiratory symptoms. An earlier study by Falsey and colleagues of respiratory illness reflected similar results to ours substantiating the opportunity for more judicious antimicrobial use based on the results of RP and PCT [14] . In this single-center study, patients were deemed to have a pure viral infection if a viral test was positive, all bacterial tests were negative, and serum PCT levels were.25 lg/mL on admission and day two of hospitalization. Duration of inpatient antibiotics was found to be significantly less in the viral alone group as compared to the mixed viral-bacterial group with means of 4.2 vs 6.2 days, respectively. These data suggest an opportunity in the use of combining RP and PCT results to narrow the etiologic diagnosis and perhaps decrease unnecessary antibiotic exposure.

While mixed viral-bacterial infection was noted in 40% of patients, the utilized diagnostic battery appeared to distinguish these from pure viral infections. It is also notable, however, that while RP and PCT results suggesting pure viral infections resulted in shorter durations of antibiotic therapy, the average duration of therapy extended more than 2 days beyond the availability results of RP and PCT testing. Recently, in a follow-up study, antibiotic prescribing patterns associated with low PCT and positive viral RP results in patients with non-pneumonic lower respiratory tract infections were characterized into two groups of patients, one receiving standard of care and the second receiving care specified by use of PCT algorithms and viral testing [15] . The investigators observed antibiotic discontinuation rates of 57% when PCT was.25 lg/mL and a positive viral RP was reported. This was substantially different than the 10% antibiotic discontinuation rate we observed. Several differences in study methods likely explain these disparate results.

Importantly, ''nonpneumonic'' was apparently defined as those with clinically suggestive symptoms of lower respiratory tract infection with no clear evidence of or risk factors for bacterial pneumonia. Further, as the previous study [14] was conducted at the same institution as this more recent study and the methods and results of that study were shared with medical staff prior to commencing the Proactive intervention, such as that provided by ASPs is important in ensuring meaningful use of rapid diagnostics as opposed to a lack of clinical benefit in the absence of such ASP-facilitated interventions [36, 37] . 

Deaths: final data for

Etiology of community-acquired pneumonia: increased microbiological yield with new diagnostic methods

Viral infection in adults hospitalized with community-acquired pneumonia: prevalence, pathogens, and presentation

Etiology of community-acquired pneumonia in 254 hospitalized children

Prospective study of the usefulness of sputum Gram stain in the initial approach to community-acquired pneumonia requiring hospitalization

Assessment of the usefulness of sputum Gram stain and culture for diagnosis of community-acquired pneumonia requiring hospitalization

Molecular diagnostics for detection of bacterial and viral pathogens in community-acquired pneumonia

Diagnostic and prognostic accuracy of clinical and laboratory parameters in community-acquired pneumonia

Calcitonin precursors are reliable markers of sepsis in a medical intensive care unit

Procalcitonin: how a hormone became a marker and mediator of sepsis

Procalcitonin levels predict bacteremia in patients with community-acquired pneumonia: a prospective cohort trial

Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections

Bacterial complications of respiratory tract viral illness: a comprehensive evaluation

Serum procalcitonin measurement and viral testing to guide antibiotic use for respiratory infections in hospitalized adults: a randomized controlled trial

Can an etiologic agent be identified in adults who are hospitalized for community-acquired pneumonia: results of a one-year study

Utility of serum procalcitonin values in patients with acute exacerbations of chronic obstructive pulmonary disease: a cautionary note

Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis

FACT SHEET: Over 150 Animal and Health Stakeholders Join White House Effort to Combat Antibiotic Resistance|whitehouse

Antibiotic prescribing for adults in ambulatory care in the USA, 2007-09

Antibiotic utilization for acute respiratory tract infections in U.S. emergency departments

Excessive antibiotic use for acute respiratory infections in the United States

The use of antimicrobial agents after diagnosis of viral respiratory tract infections in hospitalized adults: antibiotics or anxiolytics?

Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial

Effectiveness and safety of procalcitonin-guided antibiotic therapy in lower respiratory tract infections in ''real life'': an International, Multicenter Poststudy Survey (ProREAL)

Clinical diagnosis, viral pcr, and antibiotic utilization in community-acquired pneumonia

Impact of rapid detection of viral and atypical bacterial pathogens by real-time polymerase chain reaction for patients with lower respiratory tract infection

Incidence and characteristics of viral community-acquired pneumonia in adults

Detection of respiratory viruses and Legionella spp. by real-time polymerase chain reaction in patients with community acquired pneumonia

Lower respiratory tract virus findings in mechanically ventilated patients with severe community-acquired pneumonia

Superiority of transcriptional profiling over procalcitonin for distinguishing bacterial from viral lower respiratory tract infections in hospitalized adults

Procalcitonin and mid-regional pro-adrenomedullin test combination in sepsis diagnosis

Diagnostic and prognostic role of procalcitonin (PCT) and MR-pro-Adrenomedullin (MR-proADM) in bacterial infections

Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia

Antibiotic treatment interruption of suspected lower respiratory tract infection based on a single procalcitonin measurement at hospital admissiona randomized trial

Clinical impact of a real-time PCR assay for rapid identification of staphylococcal bacteremia

Assessment of impact of peptide nucleic acid fluorescence in situ hybridization for rapid identification of coagulase-negative staphylococci in the absence of antimicrobial stewardship intervention